Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic β-amino acid

Martin Sukopp, Richard Schwab, Luciana Marinelli, Eric Biron, Markus Heller, Edit Várkondi, A. Pap, Ettore Novellino, G. Kéri, Horst Kessler

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The cyclic somatostatin analogue cyclo[Pro1-Phe 2-D-Trp3-Lys4-Thr5-Phe6] (L-363,301) displays high biological activity in inhibiting the release of growth hormone, insulin, and glucagon. According to the sequence of L-363,301, we synthesized a number of cyclic hexa- and pentapeptides containing nonnatural α- and β-amino acids. The N-fluorenylmethoxycarbonyl protected cyclic β-amino acid [1S, 2S, 5R]-2-amino-3,5-dimethyl-2-cyclohex-3-enecarboxylic acid (cβAA), for the replacement of the Phe6-Pro1 moiety of L-363,301, was synthesized in two steps by an enantioselective multicomponent reaction using (-)-8-phenylmenthol as a chiral auxiliary. The resulting peptide cyclo[cβAA1-Tyr2-D-Trp 3-Nle4-Thr(Trt)5] (Trt = triphenylmethyl) shows high antiproliferative effects in an in vitro assay with A431 cancer cells. The same peptide without the Trt group does not reveal any biological activity, whereas L-363,301 and closely related hexapeptides show only minor activity. By comparison of the solution structure of cyclo[cβAA1-Tyr 2-D-Trp3-Nle4-Thr(Trt)5] with the structure of L-363,301, a nearly perfect match of the βII′-turn region with D-Trp in the i + 1 position was observed. The cyclic β-amino acid cβAA is likely needed for the bioactive conformation of the peptide.

Original languageEnglish
Pages (from-to)2916-2926
Number of pages11
JournalJournal of Medicinal Chemistry
Volume48
Issue number8
DOIs
Publication statusPublished - Apr 21 2005

Fingerprint

cyclo(Pro-Phe-Trp-Lys-Thr-Phe)
Cyclic Amino Acids
Structure-Activity Relationship
Somatostatin
Bioactivity
Peptides
Acids
Glucagon
Growth Hormone
Conformations
Assays
Cells
Insulin
Amino Acids

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic β-amino acid. / Sukopp, Martin; Schwab, Richard; Marinelli, Luciana; Biron, Eric; Heller, Markus; Várkondi, Edit; Pap, A.; Novellino, Ettore; Kéri, G.; Kessler, Horst.

In: Journal of Medicinal Chemistry, Vol. 48, No. 8, 21.04.2005, p. 2916-2926.

Research output: Contribution to journalArticle

Sukopp, Martin ; Schwab, Richard ; Marinelli, Luciana ; Biron, Eric ; Heller, Markus ; Várkondi, Edit ; Pap, A. ; Novellino, Ettore ; Kéri, G. ; Kessler, Horst. / Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic β-amino acid. In: Journal of Medicinal Chemistry. 2005 ; Vol. 48, No. 8. pp. 2916-2926.
@article{51967d11565c43048f35ff4e66480883,
title = "Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic β-amino acid",
abstract = "The cyclic somatostatin analogue cyclo[Pro1-Phe 2-D-Trp3-Lys4-Thr5-Phe6] (L-363,301) displays high biological activity in inhibiting the release of growth hormone, insulin, and glucagon. According to the sequence of L-363,301, we synthesized a number of cyclic hexa- and pentapeptides containing nonnatural α- and β-amino acids. The N-fluorenylmethoxycarbonyl protected cyclic β-amino acid [1S, 2S, 5R]-2-amino-3,5-dimethyl-2-cyclohex-3-enecarboxylic acid (cβAA), for the replacement of the Phe6-Pro1 moiety of L-363,301, was synthesized in two steps by an enantioselective multicomponent reaction using (-)-8-phenylmenthol as a chiral auxiliary. The resulting peptide cyclo[cβAA1-Tyr2-D-Trp 3-Nle4-Thr(Trt)5] (Trt = triphenylmethyl) shows high antiproliferative effects in an in vitro assay with A431 cancer cells. The same peptide without the Trt group does not reveal any biological activity, whereas L-363,301 and closely related hexapeptides show only minor activity. By comparison of the solution structure of cyclo[cβAA1-Tyr 2-D-Trp3-Nle4-Thr(Trt)5] with the structure of L-363,301, a nearly perfect match of the βII′-turn region with D-Trp in the i + 1 position was observed. The cyclic β-amino acid cβAA is likely needed for the bioactive conformation of the peptide.",
author = "Martin Sukopp and Richard Schwab and Luciana Marinelli and Eric Biron and Markus Heller and Edit V{\'a}rkondi and A. Pap and Ettore Novellino and G. K{\'e}ri and Horst Kessler",
year = "2005",
month = "4",
day = "21",
doi = "10.1021/jm049500j",
language = "English",
volume = "48",
pages = "2916--2926",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic β-amino acid

AU - Sukopp, Martin

AU - Schwab, Richard

AU - Marinelli, Luciana

AU - Biron, Eric

AU - Heller, Markus

AU - Várkondi, Edit

AU - Pap, A.

AU - Novellino, Ettore

AU - Kéri, G.

AU - Kessler, Horst

PY - 2005/4/21

Y1 - 2005/4/21

N2 - The cyclic somatostatin analogue cyclo[Pro1-Phe 2-D-Trp3-Lys4-Thr5-Phe6] (L-363,301) displays high biological activity in inhibiting the release of growth hormone, insulin, and glucagon. According to the sequence of L-363,301, we synthesized a number of cyclic hexa- and pentapeptides containing nonnatural α- and β-amino acids. The N-fluorenylmethoxycarbonyl protected cyclic β-amino acid [1S, 2S, 5R]-2-amino-3,5-dimethyl-2-cyclohex-3-enecarboxylic acid (cβAA), for the replacement of the Phe6-Pro1 moiety of L-363,301, was synthesized in two steps by an enantioselective multicomponent reaction using (-)-8-phenylmenthol as a chiral auxiliary. The resulting peptide cyclo[cβAA1-Tyr2-D-Trp 3-Nle4-Thr(Trt)5] (Trt = triphenylmethyl) shows high antiproliferative effects in an in vitro assay with A431 cancer cells. The same peptide without the Trt group does not reveal any biological activity, whereas L-363,301 and closely related hexapeptides show only minor activity. By comparison of the solution structure of cyclo[cβAA1-Tyr 2-D-Trp3-Nle4-Thr(Trt)5] with the structure of L-363,301, a nearly perfect match of the βII′-turn region with D-Trp in the i + 1 position was observed. The cyclic β-amino acid cβAA is likely needed for the bioactive conformation of the peptide.

AB - The cyclic somatostatin analogue cyclo[Pro1-Phe 2-D-Trp3-Lys4-Thr5-Phe6] (L-363,301) displays high biological activity in inhibiting the release of growth hormone, insulin, and glucagon. According to the sequence of L-363,301, we synthesized a number of cyclic hexa- and pentapeptides containing nonnatural α- and β-amino acids. The N-fluorenylmethoxycarbonyl protected cyclic β-amino acid [1S, 2S, 5R]-2-amino-3,5-dimethyl-2-cyclohex-3-enecarboxylic acid (cβAA), for the replacement of the Phe6-Pro1 moiety of L-363,301, was synthesized in two steps by an enantioselective multicomponent reaction using (-)-8-phenylmenthol as a chiral auxiliary. The resulting peptide cyclo[cβAA1-Tyr2-D-Trp 3-Nle4-Thr(Trt)5] (Trt = triphenylmethyl) shows high antiproliferative effects in an in vitro assay with A431 cancer cells. The same peptide without the Trt group does not reveal any biological activity, whereas L-363,301 and closely related hexapeptides show only minor activity. By comparison of the solution structure of cyclo[cβAA1-Tyr 2-D-Trp3-Nle4-Thr(Trt)5] with the structure of L-363,301, a nearly perfect match of the βII′-turn region with D-Trp in the i + 1 position was observed. The cyclic β-amino acid cβAA is likely needed for the bioactive conformation of the peptide.

UR - http://www.scopus.com/inward/record.url?scp=20944435317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944435317&partnerID=8YFLogxK

U2 - 10.1021/jm049500j

DO - 10.1021/jm049500j

M3 - Article

C2 - 15828830

AN - SCOPUS:20944435317

VL - 48

SP - 2916

EP - 2926

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 8

ER -